SK1702004A3 - Farmaceutický prostriedok na liečenie diabetu, jeho použitie a súprava obsahujúca tento prostriedok - Google Patents

Farmaceutický prostriedok na liečenie diabetu, jeho použitie a súprava obsahujúca tento prostriedok Download PDF

Info

Publication number
SK1702004A3
SK1702004A3 SK170-2004A SK1702004A SK1702004A3 SK 1702004 A3 SK1702004 A3 SK 1702004A3 SK 1702004 A SK1702004 A SK 1702004A SK 1702004 A3 SK1702004 A3 SK 1702004A3
Authority
SK
Slovakia
Prior art keywords
ser
leu
gly
met
pharmaceutical composition
Prior art date
Application number
SK170-2004A
Other languages
English (en)
Slovak (sk)
Inventor
Aaron I. Vinik
Lawrence Rosenberg
Gary Pittenger
David Taylor-Fishwick
Michael Salem
Scott Mohrland
Original Assignee
Gmp Endotherapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gmp Endotherapeutics, Inc. filed Critical Gmp Endotherapeutics, Inc.
Publication of SK1702004A3 publication Critical patent/SK1702004A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/474—Pancreatic thread protein; Reg protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4733—Acute pancreatitis-associated protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SK170-2004A 2001-10-16 2002-10-15 Farmaceutický prostriedok na liečenie diabetu, jeho použitie a súprava obsahujúca tento prostriedok SK1702004A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32933001P 2001-10-16 2001-10-16
PCT/US2002/032904 WO2003033808A2 (en) 2001-10-16 2002-10-15 Composition and method for treating diabetes

Publications (1)

Publication Number Publication Date
SK1702004A3 true SK1702004A3 (sk) 2005-03-04

Family

ID=23284879

Family Applications (1)

Application Number Title Priority Date Filing Date
SK170-2004A SK1702004A3 (sk) 2001-10-16 2002-10-15 Farmaceutický prostriedok na liečenie diabetu, jeho použitie a súprava obsahujúca tento prostriedok

Country Status (20)

Country Link
US (2) US20040132644A1 (cs)
EP (1) EP1435995A2 (cs)
JP (1) JP2005506362A (cs)
KR (1) KR20050036865A (cs)
CN (1) CN1723034A (cs)
BR (1) BR0213291A (cs)
CA (1) CA2463769A1 (cs)
CO (2) CO5570658A2 (cs)
CZ (1) CZ2004479A3 (cs)
HU (1) HUP0401612A3 (cs)
IL (1) IL161073A0 (cs)
MA (1) MA27503A1 (cs)
MX (1) MXPA04003526A (cs)
NO (1) NO20042012L (cs)
PE (1) PE20030608A1 (cs)
PL (1) PL370069A1 (cs)
RU (1) RU2004114865A (cs)
SK (1) SK1702004A3 (cs)
WO (1) WO2003033808A2 (cs)
ZA (1) ZA200402261B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003275853A1 (en) * 2002-10-24 2004-05-13 Mcgill University Use of ingap for reversing diabetes
US20090142338A1 (en) * 2005-03-04 2009-06-04 Curedm, Inc. Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions
WO2006096565A2 (en) * 2005-03-04 2006-09-14 Curedm Inc. Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
JP2008545712A (ja) * 2005-05-25 2008-12-18 キュアーディーエム、インク． ペプチド、その誘導体並びに類似体、及びそれらを使用する方法
EP1840573A1 (en) * 2006-03-27 2007-10-03 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
WO2008064306A2 (en) * 2006-11-22 2008-05-29 Curedm, Inc. Methods and compositions relating to islet cell neogenesis
SI2193142T1 (sl) * 2007-08-30 2015-05-29 Curedm Group Holdings, Llc Sestavek in postopek za uporabo proislet peptidov in analogov le-teh
CA2886442A1 (en) * 2012-09-27 2014-04-03 Claresa LEVETAN Generation of new pancreatic beta cells
CN104045702A (zh) * 2013-03-15 2014-09-17 深圳君圣泰生物技术有限公司 一种多肽、多肽衍生物、多肽的可药用盐及药物组合物
WO2014139182A1 (en) * 2013-03-15 2014-09-18 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
CN104045699A (zh) * 2013-03-15 2014-09-17 深圳君圣泰生物技术有限公司 一种多肽、多肽衍生物、多肽的可药用盐及药物组合物
CN104045698B (zh) * 2013-03-15 2019-04-16 深圳君圣泰生物技术有限公司 一种多肽、多肽衍生物、多肽的可药用盐及药物组合物
CN103305457B (zh) * 2013-06-06 2015-07-08 浙江省医学科学院 一种体外扩增胰岛β细胞的方法
US20160039876A1 (en) * 2014-03-28 2016-02-11 Claresa Levetan Insulin independence among patients with diabetes utilizing an optimized hamster reg3 gamma peptide
CN109195983B (zh) * 2016-03-10 2022-05-17 深圳君圣泰生物技术有限公司 胰岛新生多肽和类似物的缀合物及其方法
US20210196646A1 (en) * 2018-08-15 2021-07-01 Wake Forest University Health Sciences Improved formulations for pancreatic islet encapsulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US127624A (en) * 1872-06-04 Improvement in apparatus for elevating water
US4658957A (en) * 1985-01-28 1987-04-21 Abbott Laboratories Utility tray
US6106840A (en) * 1988-06-23 2000-08-22 Anergen, Inc. MHC conjugates useful in ameliorating autoimmunity
US5834590A (en) * 1995-02-22 1998-11-10 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Ingap protein involved in pancreatic islet neogenesis
JP4111539B2 (ja) * 1995-02-22 2008-07-02 イースタン・ヴァージニア・メディカル・スクール・オブ・ザ・メディカル・カレッジ・オブ・ハンプトン・ローズ 膵島新生に関与するｉｎｇａｐタンパク質
DK0910571T3 (da) * 1996-05-03 2005-10-31 Abbott Lab Hidtil ukendte antiangiogene peptider, polynucleotider, der koder for samme, samt fremgangsmåder til inhibering af angiogenese
US6090577A (en) * 1997-05-22 2000-07-18 Incyte Pharmaceuticals, Inc. Disease associated acidic protein
US6986994B2 (en) * 2001-01-09 2006-01-17 Gmp Endotherapeutics, Inc. INGAP displacement assays

Also Published As

Publication number Publication date
PL370069A1 (en) 2005-05-16
BR0213291A (pt) 2004-10-26
US20040132644A1 (en) 2004-07-08
CA2463769A1 (en) 2003-04-24
HUP0401612A3 (en) 2006-04-28
IL161073A0 (en) 2004-08-31
WO2003033808A2 (en) 2003-04-24
CN1723034A (zh) 2006-01-18
CO5590933A2 (es) 2005-12-30
RU2004114865A (ru) 2005-05-27
CO5570658A2 (es) 2005-10-31
NO20042012L (no) 2004-07-16
US20080171704A1 (en) 2008-07-17
EP1435995A2 (en) 2004-07-14
KR20050036865A (ko) 2005-04-20
MA27503A1 (fr) 2005-09-01
PE20030608A1 (es) 2003-08-26
JP2005506362A (ja) 2005-03-03
ZA200402261B (en) 2004-09-28
MXPA04003526A (es) 2004-07-22
HUP0401612A2 (hu) 2004-12-28
WO2003033808A3 (en) 2003-09-18
CZ2004479A3 (cs) 2005-01-12

Similar Documents

Publication Publication Date Title
US20080171704A1 (en) Composition and method for treating diabetes
US7060675B2 (en) Methods of treating diabetes mellitus
US5124314A (en) Pharmaceutical compositions containing amylin
US5939387A (en) Method of treating insulin resistance
ZA200406332B (en) ACC inhibitors.
CN107567459A (zh) 胰淀素类似物
JP2002516318A (ja) ジペプチジル・ペプチダーゼｉｖの新規エフェクター
US11414474B2 (en) Long-acting adrenomedullin derivatives
JP2004520345A (ja) 糖尿病を有する被験者にガストリン／ｃｃｋ受容体リガンド及びｅｇｆ受容体リガンド組成物を用いた島細胞新生治療方法の効果持続
AU2002244020A1 (en) Methods of treating diabetes mellitus
JP2013545782A (ja) 長時間作用型インスリンと組み合わせた速効型インスリン
JPH02101022A (ja) 糖尿病治療用医薬組成物
AU2021254623A1 (en) Long-acting adrenomedullin derivative
NL8203315A (nl) Farmaceutische preparaten, die menselijk insuline en menselijk c-peptide bevatten.
US20240130994A1 (en) Ionic liquid formulations for treating diabetes
US11028141B2 (en) Therapeutic for the prevention and/or treatment of weight gain and/or diabetes
WO2021117754A1 (ja) Ｄｎａ損傷の抑制又は修復剤
JPS6094999A (ja) インシユリン誘導体およびその製法
AU2002343519A1 (en) Composition and method for treating diabetes
JP3817122B2 (ja) 水チャンネルオープナー組成物及び眼科用医薬組成物
CN116199743A (zh) 抗焦亡多肽及其应用

Legal Events

Date Code Title Description
FC9A Refused patent application